NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The South African rand was little changed on Friday, with the global focus on U.S.-China trade talks this weekend after a U.S. deal with Britain raised hopes for progress in tariff talks with other countries.Read More